Mark SOMMERFELD

Person

Bensheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugat...
- Patent number 12,054,551
- Issue date Aug 6, 2024
- Sanofi
- Mark Sommerfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FGF21 variants
- Patent number 11,230,582
- Issue date Jan 25, 2022
- Sanofi
- Mark Sommerfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FGF21 compound / GLP-1R agonist combinations with optimized activit...
- Patent number 10,583,174
- Issue date Mar 10, 2020
- Sanofi
- Britta Göbel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin derivatives having an extremely delayed time-action profile
- Patent number 9,644,017
- Issue date May 9, 2017
- Sanofi-Aventis Deutschland GmbH
- Paul Habermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Insulin derivatives having an extremely delayed time-action profile
- Patent number 8,633,156
- Issue date Jan 21, 2014
- Sanofi-Aventis Deutschland GmbH
- Paul Habermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Insulin derivatives having an extremely delayed time-action profile
- Patent number 8,603,970
- Issue date Dec 10, 2013
- Sanofi-Aventis Deutschland GmbH
- Paul Habermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for identifying IRS inhibitors or agonists
- Patent number 7,803,571
- Issue date Sep 28, 2010
- Sanfoi-Aventis Deutschland GmbH
- Norbert Tennagels
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugat...
- Publication number 20250115669
- Publication date Apr 10, 2025
- SANOFI
- Mark SOMMERFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...
- Publication number 20240366727
- Publication date Nov 7, 2024
- SANOFI
- Britta GÖBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1R AGONIST / FGF21 FUSION PROTEINS
- Publication number 20230265152
- Publication date Aug 24, 2023
- SANOFI
- Oliver BOSCHEINEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1R AGONISTIC PEPTIDES WITH REDUCED ACTIVITY
- Publication number 20230250147
- Publication date Aug 10, 2023
- SANOFI
- Oliver BOSCHEINEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...
- Publication number 20220401523
- Publication date Dec 22, 2022
- SANOFI
- Britta GÖBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 VARIANTS
- Publication number 20220227825
- Publication date Jul 21, 2022
- SANOFI
- Mark SOMMERFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugat...
- Publication number 20220010021
- Publication date Jan 13, 2022
- SANOFI
- Mark SOMMERFELD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...
- Publication number 20200261542
- Publication date Aug 20, 2020
- SANOFI
- Britta GÖBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME
- Publication number 20190085043
- Publication date Mar 21, 2019
- SANOFI
- Oliver BOSCHEINEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 VARIANTS
- Publication number 20180371041
- Publication date Dec 27, 2018
- SANOFI
- Mark SOMMERFELD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...
- Publication number 20180236037
- Publication date Aug 23, 2018
- SANOFI
- Britta GÖBEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME
- Publication number 20180236033
- Publication date Aug 23, 2018
- SANOFI
- Mark Sommerfeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME
- Publication number 20160279199
- Publication date Sep 29, 2016
- SANOFI
- Mark Sommerfeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fusion proteins comprising FGF-21 and GLP-1R agonist
- Publication number 20160194371
- Publication date Jul 7, 2016
- SANOFI
- Oliver Boscheinen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutical Composition for Treating a Metabolic Syndrome
- Publication number 20150231210
- Publication date Aug 20, 2015
- SANOFI
- Mark SOMMERFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Composition for Treating A Metabolic Syndrome
- Publication number 20140142023
- Publication date May 22, 2014
- SANOFI
- Mark Sommerfeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME
- Publication number 20140073563
- Publication date Mar 13, 2014
- SANOFI
- Oliver BOSCHEINEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME
- Publication number 20130203651
- Publication date Aug 8, 2013
- SANOFI
- Mark Sommerfeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL INSULIN DERIVATIVES HAVING AN EXTREMELY DELAYED TIME-ACTION P...
- Publication number 20110173722
- Publication date Jul 14, 2011
- Sanofi-Aventis Deutschland GmbH
- Paul HABERMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL INSULIN DERIVATIVES HAVING AN EXTREMELY DELAYED TIME-ACTION P...
- Publication number 20110077197
- Publication date Mar 31, 2011
- Sanofi-Aventis Deutschland GmbH
- Paul HABERMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for the identification of IRS protein kinase inhibitors or a...
- Publication number 20050106653
- Publication date May 19, 2005
- Aventis Pharma Deutschland GmbH
- Norbert Tennagels
- C07 - ORGANIC CHEMISTRY

Mark SOMMERFELD

Person

Patents Grantslast 30 patents

FGFR1/KLB targeting agonistic antigen-binding proteins and conjugat...

FGF21 variants

FGF21 compound / GLP-1R agonist combinations with optimized activit...

Insulin derivatives having an extremely delayed time-action profile

Insulin derivatives having an extremely delayed time-action profile

Insulin derivatives having an extremely delayed time-action profile

Method for identifying IRS inhibitors or agonists

Patents Applicationslast 30 patents

FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugat...

FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...

GLP-1R AGONIST / FGF21 FUSION PROTEINS

GLP-1R AGONISTIC PEPTIDES WITH REDUCED ACTIVITY

FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...

FGF21 VARIANTS

FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugat...

FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...

FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME

FGF21 VARIANTS

FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVIT...

PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME

PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME

Fusion proteins comprising FGF-21 and GLP-1R agonist

Pharmaceutical Composition for Treating a Metabolic Syndrome

Pharmaceutical Composition for Treating A Metabolic Syndrome

FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME

PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME

NOVEL INSULIN DERIVATIVES HAVING AN EXTREMELY DELAYED TIME-ACTION P...

NOVEL INSULIN DERIVATIVES HAVING AN EXTREMELY DELAYED TIME-ACTION P...

Method for the identification of IRS protein kinase inhibitors or a...